BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16607050)

  • 1. Predictive impact of the inducibility of ventricular fibrillation in patients with Brugada-type ECG.
    Imaki R; Niwano S; Fukaya H; Sasaki S; Yuge M; Hirasawa S; Sato D; Sasaki T; Moriguchi M; Izumi T
    Int Heart J; 2006 Mar; 47(2):229-36. PubMed ID: 16607050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome.
    Eckardt L; Bruns HJ; Paul M; Kirchhof P; Schulze-Bahr E; Wichter T; Breithardt G; Borggrefe M; Haverkamp W
    J Cardiovasc Electrophysiol; 2002 Aug; 13(8):742-9. PubMed ID: 12212690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome.
    Kanda M; Shimizu W; Matsuo K; Nagaya N; Taguchi A; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2002 Jun; 39(11):1799-805. PubMed ID: 12039494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relatively benign clinical course in asymptomatic patients with brugada-type electrocardiogram without family history of sudden death.
    Takenaka S; Kusano KF; Hisamatsu K; Nagase S; Nakamura K; Morita H; Matsubara H; Emori T; Ohe T
    J Cardiovasc Electrophysiol; 2001 Jan; 12(1):2-6. PubMed ID: 11204079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart.
    Brugada P; Brugada R; Mont L; Rivero M; Geelen P; Brugada J
    J Cardiovasc Electrophysiol; 2003 May; 14(5):455-7. PubMed ID: 12776858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification for asymptomatic patients with Brugada syndrome.
    Morita H; Takenaka-Morita S; Fukushima-Kusano K; Kobayashi M; Nagase S; Kakishita M; Nakamura K; Emori T; Matsubara H; Ohe T
    Circ J; 2003 Apr; 67(4):312-6. PubMed ID: 12655161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome.
    Sunsaneewitayakul B; Yao Y; Thamaree S; Zhang S
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S10-6. PubMed ID: 22988965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of signal-averaged electrocardiograms for predicting the inducibility of ventricular fibrillation in the syndrome consisting of right bundle branch block and ST segment elevation in leads V1-V3.
    Masaki R; Watanabe I; Nakai T; Kondo K; Oshikawa N; Sugimura H; Okubo K; Kojima T; Saito S; Ozawa Y; Kanmatsuse K
    Jpn Heart J; 2002 Jul; 43(4):367-78. PubMed ID: 12227712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy.
    Kakishita M; Kurita T; Matsuo K; Taguchi A; Suyama K; Shimizu W; Aihara N; Kamakura S; Yamamoto F; Kobayashi J; Kosakai Y; Ohe T
    J Am Coll Cardiol; 2000 Nov; 36(5):1646-53. PubMed ID: 11079671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of electrocardiographic abnormalities associated with initial ventricular fibrillation in asymptomatic patients with Brugada syndrome.
    Morita H; Miyamoto M; Watanabe A; Tsukuda S; Morimoto Y; Kawada S; Nakagawa K; Nishii N; Ito H
    Heart Rhythm; 2018 Oct; 15(10):1468-1474. PubMed ID: 29953954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular fibrillation induction and diffuse abnormal ST-segment response to ajmaline in a patient with apparent pre-existing dynamic right bundle branch block.
    Nguyen BL; Tufano F; De Angelis S; Tersigni F; Alessandri N; Brugada P
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3115-9. PubMed ID: 25392113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome.
    Noda T; Shimizu W; Taguchi A; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2002 Nov; 40(10):1841-7. PubMed ID: 12446069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3.
    Brugada J; Brugada R; Antzelevitch C; Towbin J; Nademanee K; Brugada P
    Circulation; 2002 Jan; 105(1):73-8. PubMed ID: 11772879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic and electrophysiologic characteristics in patients with Brugada type electrocardiogram and inducible ventricular fibrillation: single center experience.
    Ohkubo K; Watanabe I; Takagi Y; Okumura Y; Ashino S; Kofune M; Kawauchi K; Yamada T; Kofune T; Hashimoto K; Shindo A; Sugimura H; Nakai T; Saito S; Hirayama A
    Circ J; 2007 Sep; 71(9):1437-41. PubMed ID: 17721024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced Brugada syndrome.
    Goethals P; Debruyne P; Saffarian M
    Acta Cardiol; 1998; 53(3):157-60. PubMed ID: 9793569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest.
    Ikeda T; Takami M; Sugi K; Mizusawa Y; Sakurada H; Yoshino H
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):396-403. PubMed ID: 16255748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is this a philosophic issue? Do patients with drug-induced Brugada type ECG have poor prognosis? (Pro).
    Shimizu A
    Circ J; 2010 Nov; 74(11):2455-63. PubMed ID: 20962432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.